The termination of a woman’s menstrual cycle is known as menopause. It occurs when a woman’s ovaries cease producing oestrogen and she stops ovulating.
The term ‘menopause’ refers to the end of a woman’s menstrual cycle. It’s a normal occurrence that marks the end of the reproductive years, just like the first menstrual cycle during adolescence does.
Many women, although not all, suffer unpleasant symptoms such as hot flushes, night sweats, sleep disturbances, and vaginal dryness before and after menopause. These symptoms and physical changes can be treated in a variety of ways, including lifestyle modifications like eating better and exercising more, as well as hormone replacement medication (HRT).
While HRT lowers the risk of several severe illnesses including osteoporosis, colorectal (bowel) cancer, and heart disease, when used as a pill, it also increases the risk of blood clots and breast cancer. You can estradiol valerate injection buy online for hormone replacement therapy.
The term “premature menopause” refers to when a woman’s last menstrual cycle occurs before the age of 40. Early menopause occurs when a woman’s last menstrual cycle occurs before the age of 45. HRT is strongly advised for women who experience premature or early menopause until they reach the typical age of menopause (approximately 51 years), unless there is a medical reason why they should not.
HRT and menopause symptoms
Symptoms of menopause that may be alleviated with HRT include
- Night sweats and hot flushes
- Dryness of the vaginal canal
- the vaginal walls are thinned
- Infections of the vaginal and bladder
- urinary incontinence (mild)
- pains and aches
- Sleep disturbances and insomnia
- memory loss and other cognitive changes
- sex desire is decreased
- a change in mood
- strange feelings under the skin, such as prickling or creeping palpitations
- hair loss or hair growth that isn’t typical
Eyes that are dry and scratchy.
Depending on the symptoms and risk factors, additional treatments such as vaginal oestrogen products, antidepressants, or other medicines may be utilized. Consult your physician for assistance.
HRT has other advantages.
HRT lowers the risk of a variety of chronic diseases that might afflict postmenopausal women, such as
HRT prevents additional bone density loss, preserves bone integrity, and lowers the risk of fractures during menopause, although it is not typically advised as the first line of treatment for Especially in younger postmenopausal women, osteoporosis (under the age of 60)
Bowel cancer – HRT decreases the risk of colorectal cancer by a little amount (bowel cancer)
When HRT is administered around the time of menopause, it has been proven to decrease cardiovascular disease indicators.
HRT’s side effects
HRT must be administered to each woman on an individual basis. Depending on the kind and amount of HRT, some women have adverse effects during the early phases of therapy. These adverse effects, which include breakthrough bleeding, breast soreness, bloating, and nausea, generally subside during the first two months of therapy.
Health concerns associated with HRT
While HRT/MHT may lower the risk of certain disabling diseases, it may also raise the risk of others. These little dangers must be weighed against the advantages of HRT for each woman. Any issues you may have should be discussed with your doctor.
HRT and breast cancer
Breast cancer risk is low or non-existent in women over 50 who take combined oestrogen and progestogen (progesterone) replacement for less than five years. Women who have been on combination HRT for more than five years are at a slightly higher risk. Up to 15 years of oestrogen use, there is no increased risk for women.
There is no evidence that a woman who uses HRT and has a family history of breast cancer is at an increased risk of getting breast cancer. I found genuine progynon depot and then got progynon depot fake product, Finally I got it alternative for progynon depot at safehealths site.
The risk of using a combination of oestrogen and progestogen is higher than using only oestrogen or using newer HRT drugs like tibolone (marketed as Livial or Xyvion), and it may also depend on the kind of progestogen used. According to studies, norethisterone and medroxyprogesterone acetate pose a greater danger than dydrogesterone and progesterone.
HRT and cardiovascular disease
On combined oral (tablet) HRT, women over 60 had a slight increased risk of heart disease or stroke. Although the increase in risk is minor, it should be taken into account before beginning HRT because it begins early in the treatment and continues over time.
When taken as a pill, oestrogen raises the risk of stroke much more, but not when administered as a skin patch. Tibolone, too, raises the risk of stroke in women starting in their mid-60s. Women who start hormone replacement therapy around menopause have a lower risk of cardiovascular disease than those who wait until they are 60 years old.
HRT and venous thrombosis
Blood clots that develop inside veins are known as venous thromboses. Women under the age of 50, as well as those between the ages of 50 and 60, are at an increased risk of venous thrombosis if they use oral HRT. The increase in risk appears to be greatest during the first year or two of treatment, particularly in women who already have a high blood clot risk. This is especially true for women who have a hereditary susceptibility to thrombosis and would otherwise be recommended against using HRT.